Polymyalgia Rheumatica
📧 Sign up to get email alerts when something new happens for Polymyalgia Rheumatica.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Update: Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE) [Phase 3]
Phase 3 study evaluating efficacy and safety of olokizumab in polymyalgia rheumatica is active not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Update: A Phase III Study of the Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica [Phase 3]
Phase III trial evaluating the efficacy and safety of olokizumab in polymyalgia rheumatica is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS [Phase 3]
Phase 3 trial on abatacept for early onset polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) [Phase 3]
Open-label, long-term safety study of secukinumab in polymyalgia rheumatica is active/not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR [Phase 1]
Phase 1 study evaluating the pharmacokinetics, safety, and tolerability of intravenous secukinumab in patients with Giant Cell Arteritis or …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) [Phase 3]
Phase 3 trial comparing secukinumab to placebo, in combination with a glucocorticoid taper regimen, in patients with Polymyalgia Rheumatica …
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed [Phase 3]
A Phase 3 trial evaluated whether rituximab can decrease glucocorticoid exposure in patients recently diagnosed with polymyalgia rheumatica …
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR) [Phase 1]
This clinical trial update reports the termination of a Phase 1 study evaluating prednisolone in combination with SPI-62 for polymyalgia rhe…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR) [Phase 2]
A Phase 2 trial assessing prednisolone with SPI-62 versus placebo in polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Validation of the PMR Activity Score and Evolution of Patient-reported Outcomes in Patients With Polymyalgia Rheumatica
This study reports the validation of the Polymyalgia Rheumatica Activity Score and the evolution of patient-reported outcomes in PMR patient…
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 [Phase 2]
A Phase 2 study evaluating subcutaneous ABBV-154 for Polymyalgia Rheumatica was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: BAriCitinib Healing Effect in earLy pOlymyalgia Rheumatica [Phase 2]
Phase 2 trial update for bari-citinib in polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica [Phase 2]
Phase 2 trial evaluating tofacitinib as a glucocorticoid-sparing agent in polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of sarilumab in polymyalgia rheumatica has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-20Clinical Trial Update: Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS [Phase 3]
A Phase 3 clinical trial update for abatacept in early-onset polymyalgia rheumatica (ALORS) is reported with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE) [Phase 3]
Phase 3 trial evaluating tocilizumab for remission-induction and glucocorticoid-sparing therapy in new-onset polymyalgia rheumatica has comp…
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE [Phase 3]
Phase 3 trial assessing safety and efficacy of tocilizumab versus placebo in glucocorticoid-dependent polymyalgia rheumatica has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica [Phase 2]
Phase 2 clinical trial update on low-dose interleukin-2 for polymyalgia rheumatica.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Treatment With Leflunomide in Patients With Polymyalgia Rheumatica [Phase 3]
Phase 3 clinical trial evaluating leflunomide for polymyalgia rheumatica is in an update, status not specified.
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR [Phase 3]
Phase 3 trial comparing Lodotra to prednisone IR in polymyalgia rheumatica was terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-05Clinical Trial Update: Timed Release Tablet Prednisone in Polymyalgia Rheumatica [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated timed release prednisone for polymyalgia rheumatica; status completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Study of Tocilizumab to Treat Polymyalgia Rheumatica [Phase 2]
Phase 2 clinical trial evaluating tocilizumab for treatment of polymyalgia rheumatica has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Delayed Release Prednisone in PMR [Phase 2]
A Phase 2 study evaluating delayed-release prednisone for polymyalgia rheumatica has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
This completed clinical trial investigates lymphocyte and cytokine disturbances in polymyalgia rheumatica. The sponsor is University Hospita…